Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Shares Outstanding (Diluted Average) (2024)

Addex Therapeutics' Shares Outstanding (Diluted Average) history spans 1 years, with the latest figure at $45.66 for Q4 2024.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed N/A to $45.66 in Q4 2024 year-over-year; TTM through Dec 2024 was $45.66, a N/A change, with the full-year FY2024 number at $45.66, changed N/A from a year prior.
  • Shares Outstanding (Diluted Average) came in at $45.66 for Q4 2024, down from $57.71 in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $143.75 in Q2 2024, with the low at $45.66 in Q4 2024.